{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:33:55Z","timestamp":1761676435098,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Pacific Southwest Regional Center of Excellence","award":["U54AI065359"],"award-info":[{"award-number":["U54AI065359"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.059","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T06:17:18Z","timestamp":1470464238000},"page":"4507-4513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release"],"prefix":"10.1016","volume":"34","author":[{"given":"Aurelie","family":"Kern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chensheng W.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaobing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linden T.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.07.059_b0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrmicro2714","article-title":"Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes","volume":"10","author":"Radolf","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.07.059_b0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","article-title":"Epidemiology of Lyme disease","volume":"29","author":"Mead","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2016.07.059_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.07.059_b0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/oxfordjournals.aje.a115306","article-title":"Comparing the relative potential of rodents as reservoirs of the Lyme disease spirochete (Borrelia burgdorferi)","volume":"130","author":"Mather","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.07.059_b0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4269\/ajtmh.1987.36.92","article-title":"Reservoir competence of white-footed mice for Lyme disease spirochetes","volume":"36","author":"Donahue","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.07.059_b0030","first-page":"343","article-title":"Ecology of Lyme disease","volume":"53","author":"Anderson","year":"1989","journal-title":"Conn Med"},{"key":"10.1016\/j.vaccine.2016.07.059_b0035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/322304a0","article-title":"Rabies control. Vaccination of wildlife reservoirs","volume":"322","author":"Anderson","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.07.059_b0040","first-page":"27","article-title":"The wild side of disease control at the wildlife-livestock-human interface: a review","volume":"1","author":"Gortazar","year":"2014","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2016.07.059_b0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.07.059_b0050","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/iai.61.6.2553-2557.1993","article-title":"OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection","volume":"61","author":"Fikrig","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.07.059_b0055","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1128\/iai.65.8.3146-3150.1997","article-title":"OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks","volume":"65","author":"de Silva","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.07.059_b0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/153036601750137705","article-title":"OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks","volume":"1","author":"Tsao","year":"2001","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2016.07.059_b0065","doi-asserted-by":"crossref","first-page":"18159","DOI":"10.1073\/pnas.0405763102","article-title":"An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle","volume":"101","author":"Tsao","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.07.059_b0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/CVI.05226-11","article-title":"Reservoir targeted vaccine for Lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice","volume":"18","author":"Meirelles Richer","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.07.059_b0075","first-page":"185","article-title":"Elimination of terrestrial rabies in Western European countries","volume":"119","author":"Cliquet","year":"2004","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2016.07.059_b0080","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0065-3519(99)80043-3","article-title":"Vaccination of wildlife against rabies: successful use of a vectored vaccine obtained by recombinant technology","volume":"41","author":"Mackowiak","year":"1999","journal-title":"Adv Vet Med"},{"key":"10.1016\/j.vaccine.2016.07.059_b0085","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.vaccine.2005.10.044","article-title":"Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs","volume":"24","author":"Scheckelhoff","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.059_b0090","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1016\/j.vaccine.2011.07.100","article-title":"Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease","volume":"29","author":"Bhattacharya","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.059_b0095","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJMoa010560","article-title":"Human infection due to recombinant vaccinia-rabies glycoprotein virus","volume":"345","author":"Rupprecht","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.07.059_b0100","unstructured":"Centers for Disease Control and Prevention (CDC). Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania, 2009. MMWR Morb Mortal Wkly Rep 2009;58:1204-7."},{"key":"10.1016\/j.vaccine.2016.07.059_b0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i4.10","article-title":"Targeted delivery of drugs to the gastrointestinal tract","volume":"18","author":"Lavelle","year":"2001","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.vaccine.2016.07.059_b0110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/17425247.3.6.747","article-title":"Delivery systems and adjuvants for oral vaccines","volume":"3","author":"Lavelle","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.vaccine.2016.07.059_b0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/17425247.2013.736962","article-title":"Eudragit: a technology evaluation","volume":"10","author":"Thakral","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.vaccine.2016.07.059_b0120","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/mabi.200700102","article-title":"Characterization of the inhibition of enveloped virus infectivity by the cationic acrylate polymer eudragit E100","volume":"7","author":"Alasino","year":"2007","journal-title":"Macromol Biosci"},{"key":"10.1016\/j.vaccine.2016.07.059_b0125","article-title":"Generation of recombinant vaccinia viruses","author":"Earl","year":"2001","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1016\/j.vaccine.2016.07.059_b0130","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1016\/j.vaccine.2007.09.023","article-title":"Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice","volume":"25","author":"Sharon","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.059_b0135","doi-asserted-by":"crossref","first-page":"e18924","DOI":"10.1371\/journal.pone.0018924","article-title":"Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus","volume":"6","author":"Mota","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.07.059_b0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/mrm.10207","article-title":"Gastrointestinal transit times in mice and humans measured with 27Al and 19F nuclear magnetic resonance","volume":"48","author":"Schwarz","year":"2002","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.vaccine.2016.07.059_b0145","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tvjl.2006.10.005","article-title":"The potential of oral vaccines for disease control in wildlife species","volume":"174","author":"Cross","year":"2007","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2016.07.059_b0150","first-page":"178","article-title":"Elimination of terrestrial rabies in Germany using oral vaccination of foxes","volume":"125","author":"M\u00fcller","year":"2012","journal-title":"Berl Munch Tierarztl Wochenschr"},{"key":"10.1016\/j.vaccine.2016.07.059_b0155","doi-asserted-by":"crossref","first-page":"947","DOI":"10.20506\/rst.15.3.965","article-title":"Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America","volume":"15","author":"Brochier","year":"1996","journal-title":"Rev \u2013 Off Int Epizoot"},{"key":"10.1016\/j.vaccine.2016.07.059_b0160","doi-asserted-by":"crossref","unstructured":"Tripp DW, Rocke TE, Streich SP, Abbott RC, Osorio JE, Miller MW. Apparent field safety of a Racoon poxvirus-vectored plague vaccine in free-ranging prairie dogs (Cynomys spp.), Colorado, USA. vol. 51. The Society for the Experimental Analysis of Behavior, Inc., Department of Psychology, Indiana University, Bloomington, Indiana 47405; 2015. http:\/\/dx.doi.org\/10.7589\/2014-02-051.","DOI":"10.7589\/2014-02-051"},{"key":"10.1016\/j.vaccine.2016.07.059_b0165","doi-asserted-by":"crossref","unstructured":"Rocke TE, Pussini N, Smith SR, Williamson J, Powell B, Osorio JE. Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (cynomys ludovicianus). <http:\/\/DxDoiorg\/101089\/Vbz20090050> 2010;10:53\u20138. http:\/\/dx.doi.org\/10.1089\/vbz.2009.0050.","DOI":"10.1089\/vbz.2009.0050"},{"key":"10.1016\/j.vaccine.2016.07.059_b0170","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.vaccine.2004.01.030","article-title":"Limited infection upon human exposure to a recombinant raccoon pox vaccine vector","volume":"22","author":"Rocke","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.059_b0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2005.04.008","article-title":"Evaluation of Eudragit-coated Chitosan microparticles as an oral immune delivery system","volume":"297","author":"Hori","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2016.07.059_b0180","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/S0264-410X(99)00140-1","article-title":"PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems","volume":"17","author":"Delgado","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.059_b0185","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm.2866","article-title":"Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection","volume":"18","author":"Zhu","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.07.059_b0190","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/jps.23220","article-title":"Immunogenicity and protection of oral influenza vaccines formulated into microparticles","volume":"101","author":"Shastri","year":"2012","journal-title":"J Pharm Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T07:43:22Z","timestamp":1657007002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":38,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X16306570"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live-vaccinia virus encapsulation in pH-sensitive polymer increases safety of a reservoir-targeted Lyme disease vaccine by targeting gastrointestinal release","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}